Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor

… additional results from its NATIVE Phase IIb clinical trial … these results from the NATIVE trial demonstrates the potential … This cardiometabolic dataset from the NATIVE Phase IIb clinical trial … in 71 sites in Australia, Canada, Europe, Mauritius and the …… additional results from its NATIVE Phase IIb clinical trial … these results from the NATIVE trial demonstrates the potential … This cardiometabolic dataset from the NATIVE Phase IIb clinical trial … in 71 sites in Australia, Canada, Europe, Mauritius and the …